The renoprotective effects of Ursodeoxycholic acid in patients with type 1 diabetes and albuminuria
Latest Information Update: 01 Jun 2023
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Proteinuria; Renal failure
- Focus Therapeutic Use
- Acronyms UREDIA
- 31 May 2023 Status changed from recruiting to completed.
- 11 May 2021 Status changed from suspended to recruiting.
- 04 May 2020 Status changed from completed to suspended.